Cas:363-34-8 2-[(2-fluorobenzoyl)amino]acetic acid manufacturer & supplier

Chemical Name:2-[(2-fluorobenzoyl)amino]acetic acid

CAS.NO:363-34-8

Synonyms:N-(2-fluoro-benzoyl)-glycine;2-(2-Fluorobenzamido)acetic acid;2-Fluor-benzaminoessigsaeure;2-Fluor-hippursaeure;N-(2-Fluor-benzoyl)-glycin;F0347-2366;2-[(2-fluorophenyl)carbonylamino]acetic acid;2-fluorohippuric acid;(2-Fluoro-benzoylamino)-acetic acid

Molecular Formula:C₉H₈FNO₃

Molecular Weight:197.16300

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:412.7ºC at 760mmHg

Density:1.358g/cm3

Index of Refraction:

PSA:66.40000

Exact Mass:197.04900

LogP:1.03100

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-(2-fluoro-benzoyl)-glycine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2-Fluoro-benzoylamino)-acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2-Fluoro-benzoylamino)-acetic acid Use and application,2-fluorohippuric acid technical grade,usp/ep/jp grade.

Related News: After nearly ten years of growth, China’s fine chemical industry has made considerable progress. At present, China’s overall refinement rate (that is, the output value rate of fine chemicals = total value of fine chemical products / total value of chemical products * 100%) has reached about 40%. Some fine chemical products have certain international competitiveness and become important processing and exporting places of fine chemical raw materials and intermediates in the world. 2-[(2-fluorobenzoyl)amino]acetic acid manufacturer Our quality control staff then conducts analyses in the testing laboratory to examine whether the API manufactured is ultrapure. 2-[(2-fluorobenzoyl)amino]acetic acid supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry. 2-[(2-fluorobenzoyl)amino]acetic acid vendor Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients. 2-[(2-fluorobenzoyl)amino]acetic acid factory Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.